![CEO and co-founder of BioNTech, Ugur Sahin, answers journalists' questions after the European Medicines Agency (EMA) approved its COVID-19 vaccine, at the company headquarters in Mainz, Germany December 22, 2020. REUTERS/Ralph Orlowski](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/J2CECPLCH2FOHLXJVAE23IQ2CY.jpg?smart=true&auth=d7a74546307223e04a3f98b4bf13550f936d6bf1989f6b3ddef5105eebeae88c&width=400&height=225)
Chief executive and co-founder of BioNTech, Ugur Sahin, said the company aims to make 2 billion doses of its vaccine this year. Reuters
Chief executive and co-founder of BioNTech, Ugur Sahin, said the company aims to make 2 billion doses of its vaccine this year. Reuters
BioNTech could supply 3 billion vaccine doses in 2022, CEO says
The company has committed to make 2 billion doses of their two-shot vaccine this year